Chrysene derivatives and organic electrical device using the same
US-9200196-B2 · Dec 1, 2015 · US
US9520566B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9520566-B2 |
| Application number | US-201314012073-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 28, 2013 |
| Priority date | Jan 16, 2013 |
| Publication date | Dec 13, 2016 |
| Grant date | Dec 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A condensed cyclic compound represented by Formula 1 below and an organic light-emitting device (OLED) including the condensed cyclic compound are presented. Ar 1 and Ar 2 in Formula 1 are each independently one of a hydrogen atom, an aryl or heteroaryl group and an arylamino group, at least one of Ar 1 and Ar 2 being a substituted or unsubstituted 1,2,4-triazol-4-yl group; L 1 and L 2 in Formula 1 are linking groups, each independently one of a cyclic or noncyclic, saturated or unsaturated hydrocarbon group and a heteroarylene group; a and b in Formula 1 are each independently one of 0 or 1; and R 1 to R 8 in Formula 1 being each independently one of a variety of inorganic and organic substituents including cyclic or noncyclic, saturated or unsaturated and aromatic, nonaromatic or heteraromatic groups. The OLED may have a low driving voltage, a high emission efficiency and long lifespan characteristics.
Opening claim text (preview).
What is claimed is: 1. A condensed cyclic compound of Formula 1 below: Formula 1Ar 1 and Ar 2 in Formula 1 being each independently one of a hydrogen atom, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, and a substituted or unsubstituted C 1 -C 60 arylamino group, at least one of Ar 1 and Ar 2 being a substituent represented by Formula 2F below: Formula 2F, Z 11 being one of a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a methyl group, an ethyl group, a propyl group, a butyl group, a methoxy group, an ethoxy group, a phenyl group, a naphthyl group, an anthryl group, a pyridyl group, a fluorenyl group, and a quinolyl group, a plurality of Z 11 s being identical to or different from each other; p being an integer selected from 1 to 4; indicating a binding site; L 1 and L 2 in Formula 1 being each independently one of a substituted or unsubstituted C 1 -C 60 alkylene group, a substituted or unsubstituted C 3 -C 60 cycloalkylene group, a substituted or unsubstituted C 2 -C 60 alkenylene group, a substituted or unsubstituted C 5 -C 60 cycloalkenylene group, a substituted or unsubstituted C 2 -C 60 alkynylene group, a substituted or unsubstituted C 5 -C 60 cycloalkynylene group, a substituted or unsubstituted C 6 -C 60 arylene group and a substituted or unsubstituted C 5 -C 60 heteroarylene group; a and b in Formula 1 being each independently 0 or 1; and R 1 to R 8 in Formula 1 being each independently one of a hydrogen atom, a deuterium atom, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine, a hydrazone, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 3 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, —N(Q 1 )(Q 2 ) and —Si(Q 3 )(Q 4 )(Q 5 ) (where Q 1 to Q 5 are each independently one of a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a C 6 -C 60 aryl group, and a C 2 -C 60 heteroaryl group). 2. The condensed cyclic compound of claim 1 , Ar 1 and Ar 2 being each independently one of a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted pentaphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthryl group, a substituted or unsubstituted pentalenyl group, a substituted or unsubstituted indenyl group, a substituted or unsubstituted azulenyl group, a substituted or unsubstituted indacenyl group, a substituted or unsubstituted acenaphthyl group, a substituted or unsubstituted heptalenyl group, a substituted or unsubstituted phenalenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted fluoranthenyl group, a substituted or unsubstituted pyrenyl group, a substituted or unsubstituted naphthacenyl group, a substituted or unsubstituted chrysenyl group, a substituted or unsubstituted triphenylenyl group, a substituted or unsubstituted perylenyl group, a substituted or unsubstituted picenyl group, a substituted or unsubstituted hexacenyl group, a substituted or unsubstituted spiro-fluorenyl group, a substituted or unsubstituted phenoxy group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted furyl group, a substituted or unsubstituted pyrazolyl group, a substituted or unsubstituted imidazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted isoxazolyl group, a substituted or unsubstituted triazolyl group, a substituted or unsubstituted tetrazolyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or unsubstituted a pyridyl group, a substituted or unsubstituted a pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted pyridazinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted pyranyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted isothiazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted isoindolyl group, a substituted or unsubstituted indolizinyl group, a substituted or unsubstituted benzofuryl group, a substituted or unsubstituted isobenzofuryl group, a substituted or unsubstituted indazolyl group, a substituted or unsubstituted benzimidazolyl group, a substituted or unsubstituted benzoxazolyl group, a substituted or unsubstituted benzisoxazolyl group, a substituted or unsubstituted imidazopyridyl group, a substituted or unsubstituted purinyl group, a substituted or unsubstituted quinolyl group, a substituted or unsubstituted isoquinolyl group, a substituted or unsubstituted phthalazinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted naphthyridinyl group, a substituted or unsubstituted cinnolinyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted benzothiazolyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted pyridoindolyl group, a substituted or unsubstituted dibenzofuryl group, a substituted or unsubstituted phenanthridinyl group, a substituted or unsubstituted benzoquinolyl group, a substituted or unsubstituted phenazinyl group, and a substituted or unsubstituted dibenzothiophenyl group. 3. The condensed cyclic compound of claim 1 , Ar 1 and Ar 2 being each independently one of a hydrogen atom and a substituent represented by one of Formulae 2A to 2G below: Z 11 being one of a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a methyl group, an ethyl group, a propyl group, a butyl group, a methoxy group, an ethoxy group, a phenyl group, a naphthyl group, an anthryl group, a pyridyl group, a fluorenyl group, and a quinolyl group, a plurality of Z 11 s being identical to or different from each other; p being an integer selected from 1 to 7; and * indicates a binding site. 4. The condensed cyclic compound of claim 1 , Ar 1 and Ar 2 being each independently a group represented by one of Formulae 3A to 3J, at least one of Ar 1 and Ar 2 being a group represented by Formula 3J: 5. The condensed cyclic compound of claim 1 , L 1 and L 2 being each independently one of a substituted or unsubstituted phenylene group, a substituted or unsubstituted biphenylene group, a substituted or unsubstituted terphenylene group, a substituted or unsubstitut
Electricity · mapped topic
Condensed systems · CPC title
Electricity · mapped topic
Electricity · mapped topic
Electricity · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.